| The biology of uveal melanoma A Amaro, R Gangemi, F Piaggio, G Angelini, G Barisione, S Ferrini, ... Cancer and Metastasis Reviews 36, 109-140, 2017 | 227 | 2017 |
| Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models G Bianchi, R Martella, S Ravera, C Marini, S Capitanio, A Orengo, ... Oncotarget 6 (14), 11806, 2015 | 153 | 2015 |
| Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer C Marini, B Salani, M Massollo, A Amaro, AI Esposito, A Maria Orengo, ... Cell cycle 12 (22), 3490-3499, 2013 | 139 | 2013 |
| Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II B Salani, C Marini, AD Rio, S Ravera, M Massollo, AM Orengo, A Amaro, ... Scientific reports 3 (1), 2070, 2013 | 130 | 2013 |
| Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter … M Dono, G Angelini, M Cecconi, A Amaro, AI Esposito, V Mirisola, I Maric, ... British journal of cancer 110 (4), 1058-1065, 2014 | 127 | 2014 |
| Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel A Amaro, AI Esposito, A Gallina, M Nees, G Angelini, A Albini, U Pfeffer Cancer and Metastasis Reviews 33, 657-671, 2014 | 89 | 2014 |
| miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A S Caporali, A Amaro, L Levati, E Alvino, PM Lacal, S Mastroeni, F Ruffini, ... Journal of Experimental & Clinical Cancer Research 38, 1-24, 2019 | 70 | 2019 |
| A prognostic multigene classifier for squamous cell carcinomas of the larynx V Mirisola, R Mora, AI Esposito, L Guastini, F Tabacchiera, L Paleari, ... Cancer letters 307 (1), 37-46, 2011 | 64 | 2011 |
| Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice M Massollo, C Marini, M Brignone, L Emionite, B Salani, M Riondato, ... Journal of Nuclear Medicine 54 (2), 259-266, 2013 | 61 | 2013 |
| Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors A Albini, C Rosano, G Angelini, A Amaro, AI Esposito, S Maramotti, ... Current Medicinal Chemistry 21 (9), 1129-1145, 2014 | 55 | 2014 |
| Molecular evolution of colorectal cancer: from multistep carcinogenesis to the big bang A Amaro, S Chiara, U Pfeffer Cancer and Metastasis Reviews 35 (1), 63-74, 2016 | 49 | 2016 |
| IGF1 regulates PKM2 function through Akt phosphorylation B Salani, S Ravera, A Amaro, A Salis, M Passalacqua, E Millo, ... Cell cycle 14 (10), 1559-1567, 2015 | 47 | 2015 |
| Curcumin induces a fatal energetic impairment in tumor cells in vitro and in vivo by inhibiting ATP-synthase activity G Bianchi, S Ravera, C Traverso, A Amaro, F Piaggio, L Emionite, ... Carcinogenesis 39 (9), 1141-1150, 2018 | 42 | 2018 |
| Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered … A Amaro, V Mirisola, G Angelini, A Musso, F Tosetti, AI Esposito, P Perri, ... European journal of cancer 49 (15), 3353-3365, 2013 | 42 | 2013 |
| Uveal melanoma metastasis E Rossi, M Croce, F Reggiani, G Schinzari, M Ambrosio, R Gangemi, ... Cancers 13 (22), 5684, 2021 | 36 | 2021 |
| A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity … A Amaro, G Angelini, V Mirisola, AI Esposito, D Reverberi, S Matis, ... Oncotarget 7 (42), 68803, 2016 | 36 | 2016 |
| ADAM 10 correlates with uveal melanoma metastasis and promotes in vitro invasion R Gangemi, A Amaro, A Gino, G Barisione, M Fabbi, U Pfeffer, ... Pigment Cell & Melanoma Research 27 (6), 1138-1148, 2014 | 36 | 2014 |
| Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells AA Amaro, AI Esposito, V Mirisola, A Mehilli, C Rosano, DM Noonan, ... Current Medicinal Chemistry 21 (5), 630-640, 2014 | 32 | 2014 |
| Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer N Ferrari, I Granata, M Capaia, M Piccirillo, MR Guarracino, R Venè, ... Cell Communication and Signaling 15, 1-14, 2017 | 31 | 2017 |
| Combined replenishment of miR‐34a and let‐7b by targeted nanoparticles inhibits tumor growth in neuroblastoma preclinical models D Di Paolo, F Pastorino, C Brignole, MV Corrias, L Emionite, M Cilli, ... Small 16 (20), 1906426, 2020 | 28 | 2020 |
